Challenges in bioanalytical testing for ADCs, including strategies for selecting the optimal ligand-binding assay (LBA) formats. It will also address solutions for overcoming bio-reagent limitations, highlighting the application of IC-LC-MS/MS for antibody detection. Additionally, the session will cover key considerations for bioanalysis at different stages of safety evaluation, ensuring accurate and reliable data throughout ADC development.
5
0
0
Date | Time | Local Time | Room | Forum | Session | Role | Topic |
---|---|---|---|---|---|---|---|
2025-10-15 | 11:00-11:20 | 2025-10-15,11:00-11:20 | Room 4 - Guohua Hall | Special Seminars |
WuXi AppTec Seminar: Changing Drug Development Landscape With New Modalities Such as Antibody Drug Conjugates (ADC) |
Speaker | Overcoming the challenges for detecting the antibody in ADC drugs: Using ligand binding assay and LC-MS/MS assays for different cases |